Eledon Pharmaceuticals announces common stock, warrant offering, no amount given

Eledon Pharmaceuticals (ELDN) announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. All of the shares and pre-funded warrants in the proposed offering will be offered by Eledon. Leerink Partners and Cantor are acting as joint book-running managers for the offering